Precision Neuroscience Co-founder Dr. Benjamin Rapoport will be a featured panelist at the upcoming 2025 New York BCI Symposium.
He’ll join leading experts in the brain-computer interface field for the session “BCI Trials Today and Tomorrow: Industry Perspectives”, which is being moderated by
@business's
@IkeSwetlitz on October 3rd at 2:15 PM ET. The discussion will dive into trial design innovations, safety, scalability, and how brain-computer interface companies are working to accelerate approval in the fast-growing BCI field.
The
@MountSinaiNeuro hosted conference runs October 3rd–4th. Full agenda and registration details here:
nybci.com.
#NYBCI25.
If you’ll be there, don’t forget to visit the
@PrecisionNeuro_ booth — we’d love to meet you!